Newest figures come from the 10-Q for Q1 FY2024, filed Jun 7, 2024. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CNGL SEC filings page.
This page shows CANNA GLOBAL ACQUISITION CORP (CNGL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
CANNA GLOBAL ACQUISITION CORP does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
CANNA GLOBAL ACQUISITION CORP passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). No profitability signals pass, all 1 leverage/liquidity signals pass.
CANNA GLOBAL ACQUISITION CORP reported a net loss of $348K while operations used $1.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
CANNA GLOBAL ACQUISITION CORP reported -$121K in net income in Q1 2024. This represents a decrease of 111.7% from the same quarter a year earlier.
Not reported for Q1 2024.
Not reported for Q1 2024.
Not reported for Q1 2024.
Cash & Balance Sheet
CANNA GLOBAL ACQUISITION CORP held $37K in cash as of Q1 2024; long-term debt is not reported for that period.
Not reported for Q1 2024.
Not reported for Q1 2024.
Margins & Returns
None of these metrics is reported for Q1 2024.
Capital Allocation
None of these metrics is reported for Q1 2024.
CNGL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA, Interest Expense, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
CNGL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2410-Q | Q4'2310-Q | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K | Q3'2210-Q | Q2'2210-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.8M-49.1% | $12.5M-49.2% | $25.8M-89.0% | $25.3M-89.2% | $25.2M-89.2% | $24.7M-89.5% | $234.9M | $233.9M |
| Current Assets | $272K+156.6% | $229K+167.3% | $333K+268.9% | $333K+211.2% | $106K-46.4% | $86K-87.4% | $90K | $107K |
| Cash & Equivalents | $37K-49.7% | $743-98.6% | $4K-92.6% | $12-100.0% | $75K-36.3% | $54K-90.6% | $59K | $36K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | N/A | N/A | $25K0.0% | $25K0.0% | $25K0.0% | $25K0.0% | $25K | $25K |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $24.4M-29.6% | $23.7M-26.7% | $36.3M-85.0% | $35.5M-85.3% | $34.7M-85.6% | $32.4M-86.6% | $242.7M | $241.7M |
| Current Liabilities | $3.8M+103.2% | $3.4M+158.5% | $2.8M+2242.4% | $2.4M+2514.5% | $1.9M+6133.9% | $1.3M+391.4% | $120K | $93K |
| Non-Current Liabilities | $20.6M-37.2% | $20.4M-34.5% | $33.5M-86.2% | $33.0M-86.3% | $32.8M-86.4% | $31.1M-87.1% | $242.6M | $241.6M |
| Total Equity | -$11.6M-22.1% | -$11.2M-45.7% | -$10.5M-33.5% | -$10.1M-29.5% | -$9.5M-20.6% | -$7.7M-0.8% | -$7.9M | -$7.8M |
| Retained Earnings | -$11.6M-22.1% | -$11.2M-45.7% | -$10.5M-33.5% | -$10.1M-29.5% | -$9.5M-20.6% | -$7.7M-0.8% | -$7.9M | -$7.8M |
Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.
CNGL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2410-Q | Q4'2310-Q | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K | Q3'2210-Q | Q2'2210-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$403K-4.3% | -$95K+61.3% | -$85K-470.0% | -$954K-759.0% | -$387K-26.6% | -$245K+9.9% | $23K | -$111K |
| Investing Cash Flow | -$89K+59.6% | $13.5M | -$176K | $402K | -$220K | N/A | N/A | N/A |
| Financing Cash Flow | $529K-15.6% | -$13.4M | $265K | $477K+1490.5% | $627K+506.3% | N/A | $0 | $30K |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
CNGL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$11.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.07), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| CANNA GLOBAL ACQUISITION CORP CNGL | FY2023 | N/A | -$348K | N/A | $76.4M | — |
| Concord Acquisition Corp Ii CNDA | FY2025 | N/A | $556K | N/A | $96.6M | — |
| ATHENA TECHNOLOGY ACQ CORP II ATEK | FY2025 | N/A | -$1.3M | N/A | $10.1M | — |
| byNordic Acquisition Corporation BYNO | FY2025 | N/A | -$732K | N/A | $87.6M | — |
Where CANNA GLOBAL ACQUISITION CORP Ranks
Frequently Asked Questions
Is CANNA GLOBAL ACQUISITION CORP profitable?
No, CANNA GLOBAL ACQUISITION CORP (CNGL) reported a net income of -$348K in fiscal year 2023.
What is CANNA GLOBAL ACQUISITION CORP's operating cash flow?
CANNA GLOBAL ACQUISITION CORP (CNGL) recorded an outflow of $1.5M in operating cash flow during fiscal year 2023, representing cash used by core business activities.
What are CANNA GLOBAL ACQUISITION CORP's total assets?
CANNA GLOBAL ACQUISITION CORP (CNGL) had $12.5M in total assets as of fiscal year 2023, including both current and long-term assets.
What is CANNA GLOBAL ACQUISITION CORP's current ratio?
CANNA GLOBAL ACQUISITION CORP (CNGL) had a current ratio of 0.07 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.
What is CANNA GLOBAL ACQUISITION CORP's return on assets (ROA)?
CANNA GLOBAL ACQUISITION CORP (CNGL) had a return on assets of -2.8% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.
Why is CANNA GLOBAL ACQUISITION CORP's debt-to-equity ratio negative or not reported?
CANNA GLOBAL ACQUISITION CORP (CNGL) has negative shareholder equity of -$11.2M as of fiscal year 2023, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is CANNA GLOBAL ACQUISITION CORP's Piotroski F-Score?
CANNA GLOBAL ACQUISITION CORP (CNGL) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are CANNA GLOBAL ACQUISITION CORP's earnings high quality?
CANNA GLOBAL ACQUISITION CORP (CNGL) reported a net loss of $348K while operations used $1.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.